Microsphere embolism-induced up-regulation of endothelial nitric oxide synthase (eNOS) in endothelial cells of brain microvessels was found after brain ischemia. The eNOS induction preceded disruption of the blood-brain barrier following ischemia. In vascular endothelial cells, microsphere embolism-induced eNOS expression was associated with protein tyrosine nitration, which is a marker of generation of peroxynitrite. To determine whether eNOS expression and protein tyrosine nitration in vascular endothelial cells mediates the blood-brain barrier disruption in the microsphere embolism brain, we tested the eŠect of a novel calmodulin-dependent NOS inhibitor, DY-9760e, which inhibits eNOS activity and in turn protein tyrosine nitration. Concomitant with inhibition of protein tyrosine nitration in vascular endothelial cells, DY-9760e signiˆcantly inhibited BBB disruption as assessed by Evans blue excretion. DY-9760e also inhibited cleavage of poly(ADP-ribose) polymerase as a marker of the apoptotic pathway in vascular endothelial cells. Taken together with previous evidence in which DY-9760e inhibited brain edema, microsphere embolism-induced eNOS expression in vascular endothelial cells likely mediates BBB disruption and in turn brain edema. 
The strong anti-eNOS and anti-nitrotyrosine immunoreactivities were seen 24 hours after ME compared to those in sham-operated animals (modiˆed from Ref. The induction of eNOS following ME-induced permanent ischemia produces a marked increase in protein tyrosine nitration, predominantly in vascular endothelial cells. The eNOS-induced protein tyrosine nitration likely accounts for ME-induced BBB disruption, thereby causing brain edema. A novel vasoprotective agent, DY-9760e, is an attractive therapeutic drug exhibiting a potent protective action of capillary endothelial cells through inhibition of eNOS and protection of tight junction. 
